ELECTRONIC ARTICLE |
From the Division of Nutrition and Physical Activity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
| ABSTRACT |
|---|
|
|
|---|
Methods. Using a multiyear data file of the National Hospital Discharge Survey, 19791999, we analyzed the changes in obesity-associated diseases and economic costs in youths (617 years of age) over time. Diabetes, obesity, sleep apnea, and gallbladder disease were examined to explore the trend of the disease burden. Other obesity-associated diseases for which obesity was listed as a secondary diagnosis were also analyzed. Obesity-associated hospital costs were estimated from the discharges with obesity listed as a principal or secondary diagnosis.
Results. From 19791981 to 19971999, the percentage of discharges with obesity-associated diseases increased. The discharges of diabetes nearly doubled (from 1.43% to 2.36%), obesity and gallbladder diseases tripled (0.36% to 1.07% and 0.18% to 0.59%, respectively), and sleep apnea increased fivefold (0.14% to 0.75%). Ninety-six percent of discharges with a diagnosis of obesity listed obesity as a secondary diagnosis. Asthma and some mental disorders were the most common principal diagnoses when obesity was listed as a secondary diagnosis. Obesity-associated annual hospital costs (based on 2001 constant US dollar value) increased more than threefold; from $35 million (0.43% of total hospital costs) during 19791981 to $127 million (1.70% of total hospital costs) during 19971999.
Conclusions. Among all hospital discharges, the proportion of discharges with obesity-associated diseases has increased dramatically in the past 20 years. This increase has led to a significant growth in economic costs. These findings may reflect the impact of increasing prevalence and severity of obesity. Diet and physical activity interventions should be developed for weight loss and prevention of weight gain in youths.
Key Words: children adolescents obesity hospitalization comorbidities costs
Abbreviations: NHDS, National Hospital Discharge Survey ICD-9, International Classification of Diseases, Ninth Revision
| INTRODUCTION |
|---|
|
|
|---|
Obesity in children and adolescents has been associated with several important chronic diseases such as diabetes, asthma, sleep apnea, and gallbladder disease.6,7 Several studies have documented that prevalence of type 2 diabetes mellitus is increasing among children and adolescents, and obesity may be a major contributor to the increase.811 However, neither trends in the prevalence of diseases associated with obesity in youths nor their impact on health care costs have previously been examined. This study explores the trends of disease and economic burden of obesity in youths from 1979 to 1999 with use of a nationally representative population sample of hospital discharges, the National Hospital Discharge Survey (NHDS).
The term overweight is used to describe children and adolescents whose body mass index is
95th percentile for youths of the same age and gender. The NHDS, however, lists obesity as a principal or a secondary diagnosis. Therefore, we will use the term obesity in this manuscript, although the use of the term reflects the providers judgment and likely underestimates the true prevalence of overweight-associated conditions and costs.
| METHODS |
|---|
|
|
|---|
The survey design, sampling, and estimation procedures were planned to produce calendar-year estimates of inpatient stays. A detailed description of the sample design of the survey is provided elsewhere.12 In the survey, the medical information manually recorded on the sampled patients abstract was coded by National Center for Health Statistics staff who used the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). A maximum of 7 diagnostic codes was assigned for each abstract sampled. The diagnostic code listed first was used as the principal diagnosis, and subsequent diagnostic codes (second through seventh) were used as secondary diagnoses.
The survey also provided demographic information, such as age, sex, and race. Data for race were missing for a total of about 13% of all discharges from all years, and no attempt was made to impute those missing values. In addition, because most obesity-related diseases occurred with a relatively low prevalence, we did not include race or other demographic variables in our analyses.
Analyses
We analyzed the hospital discharges from 1979 to 1999 of children and adolescents 6 to 17 years of age. We selected diabetes (ICD-9 250), obesity (ICD-9 278), sleep apnea (ICD-9 780.5, 786.09, and 789.03789.07 for the year 1999 because of code changes), and gallbladder disease (ICD-9 574 and 575) for the analyses of trends. Because type 1 and type 2 diabetes cannot be reliably differentiated in our analyses, we considered only the hospitalizations in which diabetes and obesity were both listed as diagnoses as the criteria for type 2 diabetes when we analyzed hospital costs. Sleep apnea included sleep disturbances and other symptoms involving the respiratory system, and other chest symptoms such as apnea, shortness of breath, and wheezing. Gallbladder disease included cholelithiasis and cholecystitis. To examine the trend of the frequency of these diseases over the study period, we used the total number of diagnoses, including principal and secondary diagnoses during a year, and then pooled discharges from 3 consecutive years for additional analyses.
To quantify the health burden of these obesity-associated diseases over time, we estimated the number of discharges in the earliest 3-year (19791981) and the most recent 3-year (19971999) periods by principal and secondary diagnoses, separately. To understand better the obesity-associated health burden, we examined the other frequent principal diagnoses for discharges where obesity was listed as a secondary diagnosis.
On the basis of the health burden, we derived annual hospital cost by multiplying the total number of hospital stays (days of care) by the average hospital cost per day. We used an average cost per day of $249 for the community hospitals as the estimate of patient direct costs for hospital treatment during the period of 19791981.13 The average cost per day during 19971999 was $1066.14 For comparison purposes, we derived the hospital costs using year 2001 constant US dollars. We used a 5% inflation rate for this purpose. In 2001 constant dollars, the average cost per day was $694 for 19791981 and $1234 for 19971999. Because of the potential for double counting and uncertainty about the linkage between obesity and obesity-associated diseases, we included only the discharges with a diagnosis of obesity for the estimate of economic burden.
Because the NHDS used a stratified, multistage probability design, for data analysis we used SUDAAN (Research Triangle Park, NC), a statistical software package to take the complex sample design effects into account.15
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
In the NHDS data reviewed for this study, obesity was usually listed as a secondary diagnosis. One potential explanation for this finding is that obesity is not generally a reimbursable diagnosis or medical health benefit. Health care payers may not reimburse for hospitalizations for obesity, even when obesity is the disease that causes diabetes, sleep apnea, or gallbladder disease. Therefore, doctors may not list obesity as a principal or even a secondary diagnosis. Lack of reimbursement may delay the treatment of obesity and lead to lost opportunities to prevent obesity-associated diseases. Reluctance to list obesity as a diagnosis may also make our estimates of disease burdens conservative.
The frequency with which other diseases have obesity listed as a secondary diagnosis suggests that obesity may lead to many other medical conditions. Asthma and some mental disorders have been linked to obesity.6,7,1618 The frequencies with which obesity was listed as a secondary diagnosis for asthma and for several mental disorders increased from 19791981 to 19971999. Especially for mental disorders, no discharges listed obesity as a co-morbidity during 19791981, but by 19971999, obesity had become a common co-morbidity. For asthma, the frequency of discharges associated with obesity increased nearly 40%. Outcome of delivery was another common discharge that listed obesity as a co-morbidity during 19971999. The diagnosis frequency increased from 1.3% in 19791981 to 4.6% in 19971999. All of the patients in this category were girls 15 to 17 years of age with single liveborn. This increase may reflect the contribution of obesity to pregnancy complications and adverse pregnancy outcomes, such as cesarean delivery and pregnancy-induced hypertension.19
The length of stay for discharges associated with obesity was longer than that for overall discharges. Discharges with a principal or secondary diagnosis of obesity yielded more days of hospital stay in recent years (19971999) than in earlier years (19791981), whereas the days of hospital stay decreased slightly for the overall discharges. When obesity was listed as a principal diagnosis, the average length of stay was twice that of discharges listing obesity as a secondary diagnosis (13.5 days vs 6.8 days). These data may reflect the time needed to treat obesity or to implement dietary or exercise strategies, or the time necessary to implement changes within families. The increased length of stay may also suggest that obesity treatment has become more complicated in recent years. For example, because of the increasing severity of obesity, more obese individuals may require gastric surgery.
The hospital costs associated with obesity may have risen to more than $127 million per year (in 2001 constant dollars) in recent years. These costs represent more than a threefold increase. As a percentage of costs for overall hospital discharges, obesity-associated costs increased from 0.43% in 19791981 to 1.7% in 19971999. The disparity between the changes in costs and the changes in prevalence of obesity may reflect the disproportionate increase in severe obesity from the 1970s to the 1990s.
This study had several limitations. First, the discharge frequency cannot be used to assess disease prevalence because a person with multiple discharges during a year may be sampled more than once. Second, physicians awareness of obesity or willingness to list obesity as a diagnosis may change over time. We did not consider this effect in analyzing discharge frequency because of lack of information. Third, only 4 obesity-associated diseases were examined for the trend analysis of diseases, and type 1 and type 2 diabetes were not differentiated, although we included only discharges that listed both obesity and diabetes for the analysis of economic costs. Fourth, we used only discharges with an obesity diagnosis to estimate the economic burden of obesity. Therefore, our estimates are probably conservative because many persons with obesity-associated diagnoses may not have a severe enough weight problem for obesity to be listed, or doctors may not have listed obesity as a diagnosis for reimbursement reasons. Finally, we analyzed hospital costs only. Other costscosts for physician visits, medication, and indirect costs such as the effect of obesity on future earningsare considerable.20 Inclusion of these costs would further increase the economic burden.
Several strengths of this study should also be noted. First, because this study used large, nationally representative samples collected over the past 20 years, we were able to examine trends and produce national estimates of hospital use and the economic burden of obesity. Although the proportion of obesity-associated discharges was low, the trend of the proportion and its economic costs are accelerating. Second, because principal and secondary diagnoses were available, we were able to examine other major comorbidities associated with obesity. Finally, although our estimates of diseases and economic costs associated with obesity are likely to be conservative in absolute values, the data from this 20-year period portray a disturbing increase of hospital diagnoses of obesity-associated diseases and in health care costs.
| CONCLUSION |
|---|
|
|
|---|
| FOOTNOTES |
|---|
Reprint requests to (G.W.) 4770 Buford Hwy, MS K-46, Atlanta, GA 30341. E-mail: gbw9{at}cdc.gov
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. K. Kumanyika, E. Obarzanek, N. Stettler, R. Bell, A. E. Field, S. P. Fortmann, B. A. Franklin, M. W. Gillman, C. E. Lewis, W. C. Poston II, et al. Population-Based Prevention of Obesity: The Need for Comprehensive Promotion of Healthful Eating, Physical Activity, and Energy Balance: A Scientific Statement From American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (Formerly the Expert Panel on Population and Prevention Science) Circulation, July 22, 2008; 118(4): 428 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Janicke, J. S. Harman, K. J. Kelleher, and J. Zhang The Association of Psychiatric Diagnoses, Health Service Use, and Expenditures in Children with Obesity-related Health Conditions J. Pediatr. Psychol., June 3, 2008; (2008) jsn051v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Northrup, L. A. Cottrell, and R. A. Wittberg L.I.F.E.: A School-Based Heart-Health Screening and Intervention Program The Journal of School Nursing, February 1, 2008; 24(1): 28 - 35. [Abstract] [PDF] |
||||
![]() |
J. M. Lee, M. J. Okumura, G. L. Freed, R. K. Menon, and M. M. Davis Trends in Hospitalizations for Diabetes Among Children and Young Adults: United States, 1993 2004 Diabetes Care, December 1, 2007; 30(12): 3035 - 3039. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cawley The Cost-effectiveness of Programs to Prevent or Reduce Obesity: The State of the Literature and a Future Research Agenda Arch Pediatr Adolesc Med, June 1, 2007; 161(6): 611 - 614. [Full Text] [PDF] |
||||
![]() |
S. E. Hampl, C. A. Carroll, S. D. Simon, and V. Sharma Resource Utilization and Expenditures for Overweight and Obese Children Arch Pediatr Adolesc Med, January 1, 2007; 161(1): 11 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
J J Reilly Obesity in childhood and adolescence: evidence based clinical and public health perspectives. Postgrad. Med. J., July 1, 2006; 82(969): 429 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Feigin Prospects for the Future of Child Health Through Research JAMA, September 21, 2005; 294(11): 1373 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H. Dietz and T. N. Robinson Overweight Children and Adolescents N. Engl. J. Med., May 19, 2005; 352(20): 2100 - 2109. [Full Text] [PDF] |
||||
![]() |
M. B. Schneider and S. R. Brill Obesity in Children and Adolescents Pediatr. Rev., May 1, 2005; 26(5): 155 - 162. [Full Text] [PDF] |
||||
![]() |
Response by Robbins, Pis, Pender, and Kazanis West J Nurs Res, November 1, 2004; 26(7): 719 - 721. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||